India set to become hub for antiviral generics: Fitch
2022-01-09
It cites nod to molnupiravir for COVID It cites nod to molnupiravir for COVID India will become the largest global hub for COVID-19 antiviral generic drug production after the drug controller granted emergency-use authorisation to several pharmaceutical companies in the country to manufacture and market generic versions of molnupiravir, Fitch Solutions said on Friday. Increased…Continue Reading